Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93% Copper (click to learn more) Almonty Announces Intention to Relocate to the United States (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

PMGC Holdings Inc ELAB

Healthcare Medical Care
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.


NDAQ:ELAB - Post by User

PMGC Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(303)
•••
  • whytestocksX
Post by whytestockson Nov 22, 2024 5:46pm
47 Views
Post# 36326897

Elevai Labs Inc.&#xA0;Announces Withdrawal of Offer to Excha

Elevai Labs Inc.&#xA0;Announces Withdrawal of Offer to Excha
NEWS: $ELAB Elevai Labs Inc.&#xA0;Announces Withdrawal of Offer to Exchange and Plans to ReassessNEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ:&#xA0;ELAB) (&#x201C;Elevai&#x201D; or the &#x201C;Company&#x201D;), a leader in medical aesthetics, announced today that it is has withdrawn the previously announced offer (the &#x201C;Offer&#x201D;) to holders of...ELAB - Elevai Labs Inc.&#xA0;Announces Withdrawal of Offer to Exchange and Plans to Reassess

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities